Hoang-Lan Nguyen

Hoang-Lan Nguyen is an experienced medical writing professional currently serving as the Executive Director of Medical Writing at TORL Biotherapeutics, LLC since September 2024. Prior to this role, Hoang-Lan held the position of Director of Medical Writing and Quality Control at BeiGene from August 2021 to October 2024 and served as Director of Medical Writing at Hutchison MediPharma from March 2019 to August 2021. Hoang-Lan's career also includes experience as a Principal Medical Writer at Regeneron Pharmaceuticals, Inc. from May 2015 to March 2019 and as a Senior Medical Writer at Mesoblast Limited from November 2013 to May 2015. Hoang-Lan Nguyen earned a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from Columbia University and a Bachelor of Arts (BA) with double majors in History and Biology from the University of Pennsylvania.